Medicine composition, medicine containing medicine composition for regulating uric acid content in blood and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and drug technology, applied in the field of medicine, can solve the problems of poor curative effect, large toxic and side effects, etc., and achieve the effect of lowering blood pressure, low toxic and side effects, and dilating blood vessels
Inactive Publication Date: 2016-10-12
BEIJING KANGLIJI BIOLOGICAL TECH CO LTD
View PDF4 Cites 6 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0005] The main purpose of the present invention is to provide a pharmaceutical composition, a drug containing it for regulating uric acid concentration in blood and its application, so as to solve the problem of large toxic side effects or poor curative effect of existing uric acid regulating drugs
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0049] The composition of the pharmaceutical composition: 60g potassium citrate, 40g sodium citrate, 1.5g iron citrate, 130g calcium citrate, 0.5g manganese citrate, 4g magnesium citrate, 25g seaweed polysaccharide, 15g lutein, 35g cyanine Vegetables, 25g anisaldehyde and 100g fructan.
[0050] Preparation method: sieve the above-mentioned components, then accurately weigh each component with the required weight, mix and stir evenly, and make tablets.
Embodiment 2
[0052] The composition of the pharmaceutical composition: 72g potassium citrate, 72g sodium citrate, 3g iron citrate, 215g calcium citrate, 1.4g manganese citrate, 7g magnesium citrate, 14g seaweed polysaccharide, 7g lutein, 14g anthocyanin , 7g anisaldehyde, 86g fructan and 600g PEG 4000, 600g PEG 6000.
[0053] Preparation method: sieve the above components, then accurately weigh the required weight components, mix and stir evenly, add PEG4000 and PEG6000 to make drop pills and cool.
Embodiment 3
[0055] The composition of the pharmaceutical composition: 147g potassium citrate, 49g sodium citrate, 2g iron citrate, 148g calcium citrate, 1g manganese citrate, 15g magnesium citrate, 20g seaweed polysaccharide, 10g lutein, 30g anthocyanin, 20g anisaldehyde, 60g fructan, 4g simple syrup, 2g sodium benzoate, 2g sodium alginate, 1.5g xanthan gum, hydrochloric acid (adjust the pH of the solution to 4.0) and 3000g sterile water.
[0056] Preparation method: sieve the above-mentioned components, accurately weigh the required weight components; dissolve the weighed components in sterile water, and then add simple syrup, sodium benzoate, sodium alginate, and xanthan gum , hydrochloric acid is added dropwise to adjust the pH value of the solution to 4.0, and then sterilized and filled to prepare an oral liquid.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention provides a medicine composition, a medicine containing the medicine composition for regulating the uric acid content in blood and application thereof. The medicine composition includes a main drug, wherein the main drug includes alkaline mineral salt and optimal natural herb extract, wherein the alkaline mineral salt is one or more of soluble potassium salt, soluble sodium salt, soluble ferric salt, soluble calcium salt, soluble manganese salt and soluble magnesium salt; the natural herb extract is one or more of algal polysaccharides, lutein, anthocyanin, anisaldehyde and fructan. According to the medicine composition, addition of the alkaline mineral salt is advantageous to improve the solubility of uric acid crystal precipitation and promote drainage of uric acid; the natural herb extract is a natural ingredient, has low toxic and side effects, and is beneficial to improvement of physiological functions of a human body; and the alkaline mineral salt and natural herb extract are combined and synthesized, so that the regulating effect of the medicine composition for regulating the uric acid in blood can be improved. Therefore, the medicine composition has low toxic and side effects, and has the advantage of effectively regulating the uric acid content in blood.
Description
technical field [0001] The invention relates to the field of medicine, in particular to a pharmaceutical composition, a medicine containing the medicine for regulating the concentration of uric acid in blood and its application. Background technique [0002] There are about 1,200 mg of uric acid in the human body, about 600 mg is newly generated every day, and 600 mg is excreted at the same time, which is in a balanced state. Because many people now have unscientific diet and irregular living habits, they are more prone to hyperuricemia. Among them, the elderly are the main group of hyperuricemia due to their weak body functions. Too much uric acid produced in the body is too late to be excreted or the uric acid excretion mechanism degrades, which will lead to excessive retention of uric acid in the body. When the concentration of uric acid in the blood is greater than 7 mg / dl, the acidity of the body fluids will affect the normal function of human cells. Cause gout. Patie...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more